Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Tectonic Therapeutic Inc ( (TECX) ) has released its Q3 earnings. Here is a breakdown of the information Tectonic Therapeutic ...

Phase 2 trial initiation in patients with sleep /wake disorders results in milestone payment of US$3.5 million to Nxera Tokyo ...

This unique cocrystal composition offers a novel approach to mental health treatment. ART27.13 is a G-Protein Coupled ...

Tectonic is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (“GPCRs”). Leveraging its ...

Longboard Pharmaceuticals, Inc. ( (LBPH) ) has released its Q3 earnings. Here is a breakdown of the information Longboard Pharmaceuticals, Inc.

How do you find the right stocks to buy? It’s a simple question, but the answer can be challenging. Thankfully, there are ...

Nxera Pharma has entered a collaboration and licensing agreement with Antiverse to design antibodies for GPCRs.

Nxera Pharma & Antiverse collaborate to design novel GPCR-targeted antibody therapeutics using generative AI: Tokyo, Japan Wednesday, November 6, 2024, 13:00 Hrs [IST] Nxera Pharm ...

have today announced a multi-target partnership and licensing agreement to design antibodies for G-protein coupled receptors (GPCRs). The company noted that the collaboration combines Antiverse’s ...

Introduction to HEK 293 Cells HEK 293 cells, also known as Human Embryonic Kidney 293 cells, have become a crucial tool in ...